Tenomodulin is essential for prevention of adipocyte accumulation and fibrovascular scar formation during early tendon healing by Lin, Dasheng et al.
OPEN
Tenomodulin is essential for prevention of adipocyte
accumulation and fibrovascular scar formation during
early tendon healing
Dasheng Lin1,2, Paolo Alberton1, Manuel Delgado Caceres3, Elias Volkmer1,4, Matthias Schieker1,5 and Denitsa Docheva*,3
Tenomodulin (Tnmd) is the best-known mature marker for tendon and ligament lineage cells. It is important for tendon maturation,
running performance and has key implications for the resident tendon stem/progenitor cells (TSPCs). However, its exact functions
during the tendon repair process still remain elusive. Here, we established an Achilles tendon injury model in a Tnmd knockout
(Tnmd−/−) mouse line. Detailed analyses showed not only a very different scar organization with a clearly reduced cell proliferation
and expression of certain tendon-related genes, but also increased cell apoptosis, adipocyte and blood vessel accumulation in the
early phase of tendon healing compared with their wild-type (WT) littermates. In addition, Tnmd−/− tendon scar tissue contained
augmented matrix deposition of biglycan, cartilage oligomeric matrix protein (Comp) and fibronectin, altered macrophage profile
and reduced numbers of CD146-positive cells. In vitro analysis revealed that Tnmd−/− TSPCs exhibited significantly reduced
migration and proliferation potential compared with that of WT TSPCs. Furthermore, Tnmd−/− TSPCs had accelerated adipogenic
differentiation accompanied with significantly increased peroxisome proliferator-activated receptor gamma (Pparγ) and lipoprotein
lipase (Lpl) mRNA levels. Thus, our results demonstrate that Tnmd is required for prevention of adipocyte accumulation and
fibrovascular scar formation during early tendon healing.
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Tendon injuries are some of the most common orthopedic
problems accounting for substantial pain, disability,
and economic burden.1 While many tendon injuries are acute,
a very large number are chronic causing degenera-
tive conditions.2 Repair in either case results in the formation
of fibrovascular scar, fat deposition or heterotopic ossification
that never attains the gross, histological, or mechanical
characteristics of normal tendon.3–5 The precise mechanisms
of matrix degeneration, tissue tearing, and the subsequent
repair process remain poorly understood.1 Tenomodulin
(Tnmd) is a member of a novel class protein family
of type II transmembrane glycoproteins with a highly
conserved cleavable C-terminal cysteine-rich domain.6,7 The
Tnmd gene consists of seven exons localized on the X
chromosome and accounts for an ~1.4 kb transcript
and a predicted full-length protein consisting of 317 amino
acids.6,7 It is predominantly expressed in tendons and
ligaments, but low levels of mRNA transcripts have
also been identified in other tissues.6–9 Tnmd is the best-
known marker of the mature tendon and ligament lineage with
a suggested dual role of its C-terminal domain, namely a
pro-proliferative action with tendon/ligament cells and
anti-angiogenic potential with vascular cells.9,10 Interestingly,
loss of Tnmd expression in gene targeted mice (Tnmd−/−)
abated tenocyte proliferation, led to reduced tenocyte
density and to pathological thickening of collagen fibers
in the tendon extracellular matrix (ECM) in vivo but
caused no major changes in the tendon vasculature.11 In our
recent study, we subjected Tnmd−/− mice and their wild-type
(WT) littermates to exhaustive running tests revealing
significantly inferior running performance of the knockouts
that further worsened with training.12 In vitro analysis of
Tnmd−/− tendon stem/progenitor cells (TSPCs) showed
significantly reduced self-renewal, and augmented senes-
cence paralleled by upregulated p53 mRNA levels, which
was confirmed in vivo by detecting an increased number of
p53-positive tenocytes in Tnmd−/− Achilles tendons.13 In
addition, overexpression of Tnmd in murine mesenchymal
stem cells (MSCs) inhibited their commitment towards the
adipogenic, chondrogenic and osteogenic lineages, whilst
promoting their tenogenic differentiation.14 The above data
motivated us to further examine the potential regulatory role
of Tnmd gene in the early tendon healing stage when
major cellular and ECM events take place,3 such as vascular
and inflammatory cell invasion, intrinsic cell activation,
migration and proliferation, and ECM deposition. Hence,
the objective of this study was to investigate the functions of
Tnmd in early tendon healing in vivo and in wound healing
assays in vitro, including careful tissue phenotyping and
specific molecular target analyses, using the Tnmd−/− mouse
strain.
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Results
Tnmd−/− tendon scars have inferior gross appearance,
histological scores and cell density paralleled with
increased accumulation of adipocytes and vessels. To
analyze Tnmd involvement during early tendon healing, we
established a mouse model of full thickness Achilles tendon
injury.15 We analyzed the mice eight days after surgical
repair, a time point characterized by scar formation, vascular
and inflammatory cell invasion, high cell migration and
proliferation as well as robust ECM secretory activity.3,16
Hematoxylin–eosin (HE) staining of sectioned tendons
revealed a very different scar organization in Tnmd−/− mice,
as indicated by significantly inferior total histological scores17
(Supplementary Table 1) compared with their WT littermates
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(Figures 1a and b). Quantitatively, total cell density was
significantly lower in the Tnmd−/− mice at 8 postoperative
days (Figures 1c and d). Ectopic ossification after tenotomy
of rodent Achilles tendon at late stages of the tendon healing
process has been reported in previous studies.18–20 How-
ever, ectopic endochondral ossification was not detected in
the scar tissues in either of the genotypes following safranin
O staining at 8 days post-injury (Figure 1e). In contrast, the
mean area of adipocyte accumulation, the number of blood
vessels observed in HE staining analyses (Figures 1f–h) and
validated by immunofluorescence staining and quantification
for perilipin- (Figures 1i and j) and collagen IV-positive areas
(Figures 1i and k), were significantly increased in the scar
sites of Tnmd−/− mice compared with WT controls. We also
found increased mRNA levels of the adipogenic marker
genes, peroxisome proliferator-activated receptor gamma
(Pparγ) and lipoprotein lipase (Lpl) in the tendons of
Tnmd−/− mice through quantitative reverse transcriptase
PCR (qRT-PCR) (Figures 1l and m). Expression of fatty
acid-binding protein 4 (Fabp4), another adipogenic marker,
was unaffected (Figure 1n). The above data revealed for the
first time that the absence of Tnmd leads to an inferior
morphological outcome and lower cellular density, whilst it
activates adipocyte accumulation and adipose-related gene
expression as well as vessel numbers in the early repair
region of injured tendons.
Tnmd−/− tendons demonstrate reduced cell proliferation
and CD146-positive cell numbers, downregulated levels
of certain tendon-related genes, whilst increasing cell
apoptosis and occurrence of p53-expressing cells. To
test whether the reduction in cell numbers was due to a
decreased proliferation or increased apoptosis, we carried
out proliferative and apoptotic assays by bromodeoxyuridine
(BrdU) and terminal deoxynucleotidyl transferase-mediated
dUTP-biotin nick end labeling (TUNEL) stainings. Further-
more, immunofluorescence staining was also performed for
p53, which regulates the apoptosis in oxidative stress-
exposed tenocytes,21 and has been previously shown by us
to be elevated in the tendons of uninjured Tnmd−/− mice.11
BrdU analysis confirmed a lower number of proliferating cells
at the scar site of injured Achilles tendons in Tnmd−/− than
WT mice (Figures 2a and b). Furthermore, TUNEL assays
and immunofluorescence staining for p53 showed that
Tnmd−/− scars had an increased number of apoptotic cells
(Figures 2c–f). In order to track activated local stem/
progenitor cells at the scar site, we performed immunofluor-
escence analysis for CD146, which labels MSCs as well as
the TSPCs.22–24 The number of CD146-positive cells was
significantly lower in Tnmd−/− compared with WT mice eight
days after injury (Figures 2g and h). Following this, we
analyzed how the absence of Tnmd affects the expression
levels of tendon-associated gene markers using qRT-PCR of
Tnmd−/− and WT tendon-derived mRNA. We observed
significantly lower mRNA levels for early growth response
protein 1 and 2 (Egr1, Egr2), collagens I, III and V (Col1a1,
Col3a1, Col5a1), tenascin C (Tnc), thrombospondin 2
(Thbs2), alpha smooth muscle actin (Acta2) and transforming
growth factor beta 1 (Tgfb1) in Tnmd−/− samples (Figure 2i).
On the contrary, the relative expression levels of mohawk
(Mkx), scleraxis (Scx), cartilage oligomeric protein (Comp)
and lubricin (Prg4) displayed a dramatic increase, without
affecting those of sine oculis homeobox homolog 1 (Six1),
collagens VI and XII (Col6a1, Col12a1) and thrombospondin
4 (Thbs4) (Figure 2i). In sum, we concluded that the loss of
Tnmd causes simultaneously reduced numbers of BrdU- and
CD146-expressing cells, but an increased incidence of
TUNEL- and p53-positive cells in the tendon scar tissue
and dysregulated expression of key tendon-related transcrip-
tion factors and ECM genes, which in turn can lead to altered
tendon tissue composition during repair.
Tnmd−/− scar tissues are characterized by erroneous
ECM deposition and abnormal macrophage profile. The
ECM of tendon tissue is composed primarily of collagen I, as
well as collagen III, elastin and various proteoglycans and
mucopolysaccharides.3 Anomalies in the ECM composition
of the scar tissue after tendon injury may contribute to a poor
and delayed healing process resulting in compromised tissue
quality.20 Prompted by this observation and the gene
expression changes in Tnmd−/− tendons, we carried out an
ECM phenotyping of the scar tissues of both genotypes. First,
we performed immunofluorescence staining with an anti-C-
terminal Tnmd antibody visualizing Tnmd secretion in the
ECM of WT mice Achilles tendon, but not in Tnmd−/− mice
(Figures 3a and b). Surprisingly, three ECM proteins, namely
biglycan, Comp and fibronectin, were more expressed in
Tnmd−/− tendon healing sites than WT mice (Figures 3c–h).
The increased protein deposition of Comp in Tnmd−/−
samples was consistent with the qRT-PCR data showing
higher Comp mRNA levels in this group (Figure 2i). However,
collagens I and III, decorin, elastin, fibromodulin and lumican
were not significantly affected (Supplementary Figure 1a).
Nonetheless, picrosirious red-stained tendon sections ana-
lyzed by polarized light microscopy exhibited ECM containing
thicker collagen fibers in the scar areas and tendon ends of
Figure 1 Tnmd deficiency results in an inferior tendon repair process, lower cell density and increased adipocyte and vessel accumulation. (a) Low-magnification HE staining
indicates a very different scar organization with clear adipocyte accumulation in Tnmd−/− mice. (b) Evaluation of tendon healing using an established histological scoring system
revealed that Tnmd−/− mice had a significantly lower total histological score at 8 days postoperatively compared with WT mice. (c,d) Cell density in the healing region was
significantly lower in Tnmd−/− versusWTmice. DAPI images were analyzed by computerized image analysis with ImageJ. (e) Ectopic endochondral ossification was not revealed
by safranin O staining in the tendons of either genotype at day 8. (f–h) In HE-stained sections increased areas of adipocyte accumulation and numbers of large blood vessels were
detected in the scar region of Tnmd−/− tendons compared with WT mice. (i) Visualization of adipocytes and blood vessels in Tnmd−/− and WT Achilles tendon scars via
immunofluorescence staining for perilipin and collagen IV. (j,k) The perilipin-positive areas and number of collagen IV-labeled blood vessels were significantly higher by 8 days
after surgery in Tnmd−/− versus WT mice. (l–n) qRT-PCR revealed upregulated mRNA levels of Pparγ and Lpl, but no changes in Fabp4 expression in Tnmd−/− versus WT
tendons. For quantification in (b, d, g, h, j and k), statistical significance was calculated using two-tailed non-parametric Mann–Whitney test, n= 8 (8 animals per group; each
animal represented by 3 tissue sections). For qRT-PCR in (l, m and n), statistical significance between 2 groups was determined by unpaired Student’s t-test (two-tailed) for 5
independent experiments. *Po0.05; ***Po0.001, compared with WT. S, scar; T, tendon; yellow arrows, blood vessels; black arrows, adipocytes. Scale bars: 200 μm
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the Tnmd−/− than that of WT mice (Supplementary
Figure 1b). Our observation of the increased erroneous
ECM deposition in the repair sites of Tnmd−/− tendons
motivated us to investigate by using target-specific ELISA
whether Tnmd−/− TSPCs secrete higher amounts of biglycan
and fibronectin proteins. The obtained quantitative data
further confirmed our in vivo results by showing that the
levels of both proteins were significantly increased in the
supernatant of Tnmd−/− compared with WT TSPCs
(Figures 3i–l).
The repair of injured tendons begins with an early
inflammatory response that is associated with infiltration of
pro-inflammatory, classically activated (M1) macrophages,
whereas the secondary inflammatory response involves
Figure 2 Tnmd deficiency results in reduced cell proliferation, CD146-positive cells, increased cell apoptosis and p53-expressing cells and an altered expression of certain
tendon-related genes. (a,b) BrdU staining and quantification in the tendon scars revealed decreased proliferative cell numbers in Tnmd−/− versus WT mice at 8 days
postoperatively. (c,d) TUNEL-based analyses detecting apoptotic cells showed increased cell apoptosis in Tnmd−/−mice compared with WTmice. (e,f) Increased number of p53-
positive cells was found at day 8 in the tendons scar tissues of Tnmd−/− tendons compared with WT mice. (g,h) Immunofluorescence staining for CD146 showed that the number
of CD146-expressing cells, corresponding to local MSCs and/or TSPCs was lower in Tnmd−/− mice than WT mice. (i) Tnmd−/− tendons displayed significantly lower expression
levels for Egr1, Egr2, Col1a1, Col3a1, Col5a1, Tnc, Thbs2, Acta2 and Tgfb1 compared with WT mice. In contrast, the relative gene expression of Mkx, Scx, Comp and Prg4
displayed a dramatic increase. No effect was found for Six1, Col6a1, Col12a1 and Thbs4. For quantification in (b, d, f and h), statistical significance was calculated using two-
tailed non-parametric Mann–Whitney test, n= 8 (8 animals per group; each animal represented by 3 tissue sections). For qRT-PCR in i, statistical significance between 2 groups
was determined by unpaired Student’s t-test (two-tailed) for 5 independent experiments. *Po0.05; ***Po0.001, compared with WT. Black arrows, BrdU-positive cells. Scale
bars: 100 μm
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anti-inflammatory, alternatively activated (M2) macro-
phages.25 Recent evidence suggested that proper modulation
of inflammation in the early stages of tendon repair may lead to
improved healing.26 Interestingly, in our model, the numbers of
cells positive for CD68, (a prominent surface marker for M1
and tissue-resident macrophages), and CD80, (a M1 macro-
phage surface marker), were significantly increased
(Figures 4a–d), whilst the number of cells expressing
CD163, (a M2 macrophage surface marker), was significantly
reduced in Tnmd−/− mice compared with WT mice eight days
after injury (Figures 4e and f). These results were further
substantiated by immunofluorescence staining of F4/80, a
monoclonal antibody directed specifically against mouse
macrophages, demonstrating a significant increase of labeled
cells in the scar sites of Tnmd−/− mice (Figures 4g and h).
Collectively, this set of data shows that Tnmd deficiency leads
to erroneous ECM deposition in vivo and in vitro and leads to
an abnormal macrophage profile with pre-dominating M1
macrophages in the repair site at day 8 of tendon healing.
Tnmd−/− TSPCs show significantly lesser migratory and
proliferative capacities but have accelerated adipogenic
differentiation rate and significantly upregulated Pparγ
and Lpl mRNA expression. Figures 1c and d and
Figures 2a, b, g and h demonstrated that loss of Tnmd is
associated with significantly lower cell density and numbers
of BrdU- and CD146-positive cells in the scar tissues at day
8. These imply that Tnmd may regulate the migration and
Figure 3 The absence of Tnmd increases erroneous ECM deposition. (a,b) Immunofluorescence staining with anti-Tnmd C-terminal antibody showed Tnmd secretion in the
ECM of WTAchilles tendon, but not in Tnmd−/−. (c–h) Biglycan, Comp and fibronectin protein deposition in the tendon scar, analyzed by fluorescent digital signal quantification,
was clearly augmented in Tnmd−/− when compared with WT mice at 8 days postoperatively. (i–l) Biglycan and fibronectin protein levels from cell lysates and supernatant were
assessed by ELISA and the levels of both proteins were significantly increased in the supernatant and slightly increased in the cell lysates of Tnmd−/− versus WT TSPCs. For
quantification in (b, d, f and h), statistical significance was calculated using two-tailed non-parametric Mann–Whitney test, n= 3 (3 animals per group; each animal represented by
3 tissue sections). For ELISA in (i, j, k and l), statistical significance between 2 groups was determined by unpaired Student’s t-test (two-tailed) for two independent experiments
with two donors/genotypes. *Po0.05 compared with WT. S, scar; T, tendon ends. Scale bars: 100 μm
Tenomodulin is essential for early tendon healing
D Lin et al
5
Cell Death and Disease
self-renewal capacities of TSPCs. Therefore, we carried out
scratch assays mimicking wound closure in vitro. To estimate
the effect of ECM proteins and because of the increased
fibronectin deposition in Tnmd−/− tendons, our scratch
assays were performed on collagen I- and fibronectin-
coated dishes. Quantification of scratch closure rate after
24 h, showed that the migration speed of Tnmd−/− TSPCs
was significantly lower compared with WT TSPCs
(Figures 5a–d). This finding was further solidified by random
migration analysis after 48 h, in which forward migration index
(FMI) of multiple single cells migrating on either of the ECM
proteins was calculated (Figures 5e and f). Quantification of
velocity, accumulated and Euclidean distance, also clearly
indicated a significant reduction of Tnmd−/− TSPCs motility
compared with WT (Figures 5g–l). Furthermore, during
12 days of culture, DNA-based CyQUANT assays at various
time points showed that Tnmd−/− TSPCs proliferated
significantly slower than WT TSPCs (Figure 5m), confirming
and expanding our earlier report that Tnmd is a positive
regulator of TSPC self-renewal.13
The observed adipocyte accumulation during early tendon
healing prompted us to test whether the loss of Tnmd can
accelerate TSPCs differentiation into adipocytes. Previously,
we have observed an increased tendency of in vitro adipogen-
esis of Tnmd−/− TSPCs.13 Here we again subjected TSPCs to
adipocyte differentiation and examined the outcome in-depth.
Tnmd−/− TSPCs grown in adipogenic medium had signifi-
cantly more BODIPY 493/503 staining of neutral lipid droplets,
indicating a higher adipogenic propensity than WT TSPCs
after 7, 14 and 21 days, respectively (Figures 6a and b).
Additional analysis, with the AdipoRed reagent revealed
similar results (Figure 6c). Consistent with our in vivo results,
semi-quantitative RT-PCR and densitometric PCR band
evaluation showed that the expression levels of Pparγ and
Lpl, but not Fabp4, were significantly increased in Tnmd−/−
TSPCs compared with those of WT following 21 days of
adipogenic stimulation (Figures 6d–f). We conclude that the
lack of Tnmd in TSPCs negatively alters their migratory and
proliferative capacities, whilst accelerating their commitment
towards adipocytes and the expression of critical adipose
regulatory genes such as Pparγ and Lpl.
Discussion
Effective strategies to speed up the healing process of tendon
injuries are still not developed because the understanding of
tendon biology lags far behind that of the other components of
the musculoskeletal system, and the molecular mechanisms
controlling the migration, proliferation and fate of TSPCs
during tendon repair are not well understood.1,9 Therefore, it is
still very challenging to identify molecular targets that can be
used to develop medicinal boosters for complete and timely
repair of injured tendons or ligaments. Tnmd is a useful
phenotypic marker of mature tenocytes and ligamentocytes
that has been shown to have intriguing and diverse roles in
developing tendons and those challenged by physical
Figure 4 The lack of Tnmd alters the macrophage profile during early tendon healing. (a–h) The numbers of CD68-, CD80- and F4/80-positive cells were significantly
increased, whereas the number of CD163-positive cells was significantly reduced in the Tnmd−/− tendon scar tissues compared with WTmice. For quantification in (b, d, f and h),
statistical significance was calculated using two-tailed non-parametric Mann–Whitney test, n= 8 (8 animals per group; each animal represented by 3 tissue sections). **Po0.01;
***Po0.001, compared with WT. Scale bars: 100 μm
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exercise.9–12,27 Herein, we further explored the potential roles
of Tnmd in the tendon healing process by subjecting Tnmd−/−
mice to full thickness Achilles tendon injury and carrying out in-
depth characterization of the scar tissues at day 8 as well as
investigating certain TSPCs functions in vitro. The novel
results of this study demonstrate for the first time that the
absence of Tnmd causes inferior tendon repair process, as
shown by adipocyte accumulation and fibrovascular scar
formation during early tendon healing.
Efficient molecular modulation of tendon healing should
accelerate cell proliferation and inhibit apoptosis, or at least
not augment the number of apoptotic events.28 We have
Figure 5 The absence of Tnmd in TSPCs leads to significantly reduced cell migration and proliferation. (a–d) In vitro wound healing assays on collagen I and fibronectin
showed that Tnmd−/− TSPC scratch closure was significantly slower compared with WT TSPCs. The borders of the scratches are outlined with yellow lines. (e,f) Forward
migration index (FMI) plots showed that Tnmd−/− TSPCs were indeed less migratory than WT TSPCs. Upper arrows on each type of matrix show the start point while lower
arrows the end point of example migratory cells. (g–l) Quantification of velocity, accumulated and Euclidean distances further validated Tnmd−/−migratory deficiency. (m) During
0, 4, 8 and 12 days of culture cell growth kinetics were estimated by DNA-based CyQUANTassay revealing that the proliferation of Tnmd−/− TSPCs was significantly lower than
that of WT TSPCs. For quantification in (c, d andm), n= 4 independent experiments per group. For quantifications in randommigration, n= 3 independent experiments per group
(total of 70–80 tracks per genotype). Statistical significance was calculated using two-tailed non-parametric Mann–Whitney test. *Po0.05; **Po0.01; ***Po0.001, compared
with WT. Blue arrows, WT TSPCs; d, day; h, hour; Red arrows, Tnmd−/− TSPCs; Scale bars: 200 μm
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already reported that the tendons of Tnmd knockout mice
exhibit reduced cell density and proliferation11 concomitant
with apparent an in vitro phenotype of Tnmd−/− TSPCs, which
were significantly less self-renewing, and more senescent.13
Our current study provides further evidence that the loss of
Tnmd expression in the healing tendon results in reduced cell
density and proliferation and lower numbers of CD146-
expressing cells, as well as augmented cell apoptosis and
higher numbers of p53-positive cells. Furthermore, we show
for the first time that Tnmd−/− TSPCs also have significant
migratory deficits in two different experimental set-ups. Hence,
we suggest that Tnmd has anti-apoptotic and anti-senescence
roles and has important regulatory roles in cell migration and
proliferation during the early stage of tendon repair. The
positive association of Tnmd expression with advancement of
tendon healing was previously suggested by Tokunaga et al.29
in a growth factor-dependent model of rotator cuff healing.
Adipocyte accumulation and fibrovascular scar are common
pathological changes that occur in ruptured tendons and
ligaments.30–34 They often do not properly remodel and in
some cases continue to worsen even after surgical repair and
physiotherapy. However, little is known of the pathophysiolo-
gical pathways behind these phenomena.30–34 Persistent or
unresolved inflammation is considered amajor trigger in many
fibrotic diseases and in tendon healing has been associated
with abnormal fibrogenesis.35–37 Recent in vivo large animal
Figure 6 The absence of Tnmd in TSPCs leads to significantly accelerated adipogenic differentiation and upregulated Pparγ and Lpl expression levels. (a,b) Tnmd−/−
TSPCs grown in adipogenic medium had significantly more BODIPY 493/503 staining of neutral lipid droplets, indicating a higher propensity of these cells to form adipocytes than
WT TSPCs after 7, 14 and 21 days, respectively. (c) AdipoRed fluorescent quantitative assay confirmed these results. (d–f) Semi-quantitative RT-PCR and densitometric band
analysis revealed that the expression of the two adipogenic marker genes Pparγ and Lpl was increased, while Fabp4 levels were not significant changed in Tnmd−/− TSPCs after
21 days of adipogenic differentiation versusWT TSPCs. For quantification in b and c n= 4 independent experiments. Statistical significance was calculated using two-tailed non-
parametric Mann–Whitney test. For semi-quantitative RT-PCR, n= 5 independent experiments per group. Statistical significance between 2 groups was determined by unpaired
Student’s t-test (2-tailed). *Po0.05; **Po0.01; ***Po0.001, compared with WT. Scale bars: 200 μm
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studies showed that inflammatory factors are dramatically
upregulated within the first week after tendon injury, which in
turn stimulate the production of proteases, cause apoptosis of
tendon cells, impede the intrinsic repair process, and promote
adhesion formation.38–42 During inflammation, macrophages
have essential roles in both promoting and resolving inflam-
mation and in both facilitating and modulating tissue repair. In
an injury setting, M1 cells predominate early, whereasM2 cells
accumulate later. Hence, in tendon injury, it could be
postulated that M1 macrophages promote repair by stimulat-
ing ECM production and that M2 macrophages enter the
process to repress inflammation and clear excess ECM, a
concept that is consistent with experimental evidence.26
Disturbing the balance between these macrophage subtypes
may result in abnormal scar formation, a defective repair
process and impaired tissue function.26 In our model, Tnmd−/−
scars at day 8 exhibited higher numbers of vessels than WT
scars, and displayed a macrophage profile of predominantly
M1 cells with lower M2 numbers. This finding may help to
explain the excess ECM protein deposition of biglycan, Comp
and fibronectin, seen in Tnmd−/− tendons. Similarly, some
recent reports dealing with tendon healing demonstrated
higher expression of biglycan and Comp in the ectopic
chondro-ossification sites in injured tendon tissues.20,43 In
addition, Spiegelman et al.44 found that fibronectin protein can
regulate adipogenic gene expression. Furthermore, a study
focusing on stem cell-based therapy of tendon injuries
suggested that a lower M2 macrophage number leads to less
accumulation of CD146-positive cells and more erroneous
matrix deposition at the repair site.45 Thus, we suggest that the
absence of Tnmd leads to enhanced vascular invasion, a
prolonged inflammatory response, aggravated deposition or
delayed clearing of excessive erroneous ECM. A deficiency of
our study is that we do not describe the precise molecular
mechanism by which Tnmd regulates the above processes. At
present, we are unable to elucidate the exact Tnmd mode of
action because we do not yet know the binding partners of this
protein. Future studies are needed if we are to decipher the
Tnmd signaling pathways. It will also be important to compare
our small animal model with clinical tendon pathologies, for
example by investigating Tnmd expression levels in different
tendinopathy forms.
Interestingly, many recent studies have focused on under-
standing Tnmd involvement in obesity and diabetes.46–52 Of
interest, Senol-Cosar et al.46 suggested that Tnmd facilitates
pre-adipocyte terminal differentiation while Jiang et al.14
showed that overexpression of Tnmd actually inhibits adipo-
genesis of murineMSCs. These data suggest that Tnmdmight
have cell type-specific modes of action; a suggestion
reinforced by the contrasting observations that Tnmd causes
proliferation of tendon-derived cells but inhibits proliferation of
vascular-derived cells.9 Our results are in line with the study of
Jiang et al.14 as we showed Tnmd−/− scars had significantly
higher adipocyte accumulation and also that Tnmd−/− TSPCs
had a higher rate of differentiation into adipocytes.We propose
that the different regulatorymechanisms of the Tnmd signaling
pathway are involved in different cell types, which will be
revealed when the Tnmdmolecular network is finally mapped.
Pparγ is a transcriptional master regulator of adipogenic
differentiation and stimulates adipogenesis.53–56 Here, we
showed that concomitantly with the higher adipocyte numbers,
the lack of Tnmd significantly enhanced the expression levels
of Pparγ and Lpl in vivo and in vitro. Furthermore, we observed
that the absence of Tnmd results in dysregulated expression
of key tendon transcription factors and ECM genes and
proteins, which in turn may lead to altered scar composition
and thereby increased lipid accumulation. Gehwolf et al.57
revealed that loss of the expression of the ECM protein Sparc
drives adipocyte differentiation in tendons. Our study does not
differentiate whether the pathways underlying the induction of
adipogenesis either by Pparγ upregulation or by changes in
ECM properties operate independently of each other or in an
interdependent manner.57,58 We can not provide a conclusive
answer to this question, but we propose that Tnmd may
strongly influence adipogenesis during tendon healing
through the regulation of Pparγ expression, ECM composition
and/or by preventing TSPC adipocyte commitment.
In summary, we created an Achilles tendon injury model in
Tnmd−/−mice, that showed that loss of Tnmd results in inferior
tendon repair characterized by increased adipocyte accumu-
lation, reduced cell density, proliferation and CD146-positive
cells, increased apoptotic and p53-expressing cells, M1:M2
macrophage ratio changes, abnormal expression of tendon-
related genes, and augmented fibrovascular scar composi-
tion. Concomitant in vitro analysis of Tnmd−/− TSPCs revealed
significantly reduced migratory and proliferative capacities,
but upregulated adipogenic gene marker levels and acceler-
ated differentiation down this lineage. Thus, our results
suggest that Tnmd is required for prevention of adipocyte
accumulation and fibrovascular scar formation during the early
phase of tendon healing.
Materials and Methods
Animal model and surgical procedure. Tnmd−/− mice and their WT
littermates were used in this study. The generation of the Tnmd−/− mice and their
primary phenotype were described by Docheva and co-workers.11–13 All the mice
were on a C57BL/6 J background. Surgical procedures were performed as
previously described by Palmes et al.15 with 6-month old mice that had reached
skeletal maturity. In brief, (1) after anesthesia, the skin above the left Achilles tendon
was opened from the gastrocnemius muscle to the calcaneus; (2) using sterile
scissors, the tendon proper (~5 mm above the calcaneus) of the Achilles tendon
was fully resected; (3) the tendon ends were then connected with modified
Kirchmayr 8-0 Dermalon suture and further supported with single 10-0 Dermalon
circular suture; (4) in order to avoid suture failure due to overstretching of the
operated tendons, the movement of the talocrural joint was restricted by a cerclage
that was inserted through the tibiofibular fork and fixed between the calcaneus and
the plantar aponeurosis. This assured a more limited degree of talocrural joint
extension (~30%) but still allowed a tensile load to be actively transferred to the
healing Achilles tendon; and (5) the skin was closed. The tendons were given eight
days for repair, corresponding to the early phase of tendon healing, after which the
animals were euthanized and the whole hind limb including the Achilles tendon-
gastrocnemius muscle-calcaneus complexes were dissected and histologically
processed as described below. All procedures for animal handling prior, during and
after surgery were approved by the Animal Care and Use Committee of the
Bavarian Government (Grant Nr. 55.2-1-54-2531-57-08). Bio-statistical design of the
group size was based on the default values of α= 0.05 and β= 0.8 for type one
error and for the power as well as on pilot histological data for each genotype,
resulting in eight animals per group.
Histomorphometry. Achilles tendons within the hind limbs were fixed in 4%
paraformaldehyde (PFA; Merck, Darmstadt, Germany) overnight at 4 °C. After
fixation, specimens were decalcified in 10% ethylene diamine tetraacetic acid
(EDTA)/phosphate buffered saline (PBS) pH 8.0 (Sigma-Aldrich, Munich, Germany)
for 7 days, and embedded in paraffin or cryogenic media and then sectioned at 5 or
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10 μm for paraffin and frozen specimens, respectively. Every 10th slide was stained
with HE and slides with comparable regional planes between genotypes (where the
whole complex of gastrocnemius muscle-Achilles tendon-calcaneus was exposed)
were selected for in-depth investigation. To analyze the total histological scores on
HE-stained slides we used the established histological scoring system of Stoll
et al.17 given in Supplementary Table 1. To reveal the ectopic endochondral
ossification in the scar tissue, safranin O staining was applied using the standard
histological protocol.
For immunofluorescence, the tissue sections were treated with 2 mg/ml
hyaluronidase (Sigma-Aldrich, Steinheim, Germany) for 30 min at 37 °C in order to
increase antibody permeability. After washing and blocking with 2% bovine serum
albumin (BSA)/PBS (Sigma-Aldrich), primary antibodies against biglycan, CD68,
CD80, CD146, CD163, collagen I, collagen III, collagen IV, Comp, decorin, elastin,
fibromodulin, fibronectin, F4/80, lumican, perilipin, p53 and Tnmd (all from Abcam,
Cambridge, UK; except for Tnmd, which was provided by Denitsa Docheva) were
applied overnight at 4 °C. Next day, corresponding Alexa Fluor 546-labeled
secondary antibodies (all from Life technology, Carlsbad, CA, USA) were applied for
1 h. Then, sections were counter-stained with 4',6-diamidino-2-phenylindole (DAPI)
(Life Technology) and mounted with fluoroshield (Sigma-Aldrich). To detect
proliferating cells, 90 min prior to euthanasia all mice received intraperitoneal
injection with BrdU (50 μg/g body weight). BrdU detection was performed with a BrdU
kit according to the manufacturer’s instructions (Roche Applied Science, Penzberg,
Germany). To analyze apoptotic cells numbers, TUNEL assay was performed
according to the manufacturer’s instructions (Abcam). Photo-micrographs were taken
on the Observer Z1 microscope equipped with the Axiocam MRm camera (Carl
Zeiss, Jena, Germany). In general, all histomorphometry experiments, unless
specified otherwise in the text, were reproduced in with 8 animals per group and
representative images are shown.
In order to analyze biglycan, Comp and fibronectin levels, an automated
quantitative image analysis was performed as described in the literature.18 In brief,
using ImageJ (National Institutes of Health, Bethesda, MD, USA), the following
algorithm was applied: (1) area of interest was manually designated using the
‘drawing/selection’ tool; (2) ‘set measurements for area, integrated density and mean
gray value’ was selected from the analyze menu; (3) the corrected total cryosection
fluorescence (CTCF) representing the biglycan, Comp and fibronectin expression
detected were calculated as follows CTCF=media of integrated density− (media of
area of selected area ×mean fluorescence). Three animals per group were analyzed.
Scar nuclear density was determined on DAPI staining with ImageJ according to
Hsieh and co-workers.18 All cell nuclei (DAPI) in 3 images per scar from 3 sections
per animal with 8 animals per group were counted. To analyze adipocytes (perilipin),
blood vessels (collagen IV), cell proliferation (BrdU), apoptotic cells (TUNEL and
p53), TSPC/MSC cells (CD146) and macrophages (CD68, CD80, CD163, and F4/80)
quantification of labeled cell per scar tissue was carried out for each staining on 8
animals per group. Each animal was represented with 3 different tissue sections with
comparable planes between genotypes. The results were averaged per animal and
shown as final mean and standard deviation (S.D.) between the 8 animals per group.
The above information is given in the figure legends (8 animals per group; each
animal represented by 3 tissue sections).
Mouse TSPCs isolation and cell culture. Mouse TSPCs were isolated
as previously described by Alberton and co-workers13 from tendons of two uninjured
Tnmd−/− and WT 6-month-old mice. Tendon tissues were enzymatically treated
overnight with collagenase II (Worthington, Lakewood, NJ, USA) in Dulbecco’s
modified Eagle’s medium (DMEM)/Ham’s F-12 (1:1) (Biochrom, Berlin, Germany)
supplemented with 10% fetal bovine serum (FBS), 1% l-ascorbic-acid-2-phosphate
(both from Sigma-Aldrich, Steinheim, Germany), 1% minimum essential medium
(MEM)-Amino Acid and 1% penicillin/streptomycine (Pen/Strep) (both from
Biochrom, Berlin, Germany). Then, the cell suspension was filtered through
70 μm nylon mesh, centrifuged at 500 × g for 5 min, and resuspended in fresh
culture media. TSPCs were grown at 37 °C and 5% CO2 and passaged when 70%
confluent with the culture media changed every third day. Cells in passages 1–3
were used for experiments.
In vitro wound healing assay. These experiments were carried out
according to our previously published protocol.59 Shortly, 1 × 104 cells per cm2 were
plated on collagen I- (20 μg/Ml; Millipore, Billerica, MA, USA) or fibronectin-coated
(10 μg/Ml; Sigma-Aldrich, Steinheim, Germany) 6-well plates in low serum (2%)
medium and were allowed to form confluent cell layers for 48 h. Prior to imaging,
the layers were scratched multiple times. Time lapse photography was performed at
4 frames per h for 24 h. For each group, the areas of 12 scratches were measured
at 9 different time points from 4 independent experiments using the ImageJ ‘wound
healing’ tool.
Migration analysis. Migration analysis was performed similarly to our previous
studies.59,60 For random migration, 1.5 × 103 cells/cm2 of Tnmd−/− and WT TSPCs
were seeded on collagen I- (20 μg/ml) or fibronectin-coated (10 μg/ml) 6-well plates
and incubated for 2 h before imaging. Time lapse photography was performed at 4
frames per h for 48 h. The image data was extracted with AxioVisionLE software
(Carl Zeiss, Jena, Germany) and individual cell tracks were analyzed with ImageJ.
Random migration was expressed by calculating the forward migration index (FMI;
the ratio of the vector length to the migratory starting point), velocity, and
accumulated (cumulative track length) and Euclidian (the ordinary straight-line
length between two points) distances. Results of random TSPCs migration
measurements consist of 3 independent time lapse movies of two Tnmd−/− and WT
TSPC donors as a total number of 70–80 TSPC per genotype were tracked.
CyQUANT assays. 1.5 × 103 cells per well were plated in 6-well plates, and
the CyQUANT assay detection was performed according to the manufacturer’s
instructions (Invitrogen, Eugene, OR, USA) after 0, 4, 8 and 12 days of cell culture,
respectively. CyQUANT assay was repeated independently in 4 experiments per
time point with two TSPC donors/genotypes.
Adipogenic differentiation assays. These experiments were carried out
according to our previously published protocol.13 Briefly, 8 × 103 cells/cm2 TSPCs
were seeded in triplicates in 6-well plates, and were cultivated in an induction media
for 5 days (DMEM-high glucose with 10% FBS, 1 μM dexamethasone, 200 μM
indomethacin, 0.01 mg/ml insulin, and 500 μM 3-isobutyl-1-methylxanthine; all from
Sigma-Aldrich, Steinheim, Germany) followed by 2 days in preservation media
(DMEM-high glucose medium supplemented with 10% FBS, 0.01 mg/ml insulin).
The process was repeated for 21 days. The adipogenic differentiation was estimated
by BODIPY 493/503 staining of neutral lipid droplets (Thermo Fisher Scientific,
Waltham, MA, USA) and AdipoRed assay (Lonza, Walkersville, MA, USA). Staining
was carried out according to the manufacturer’s instructions. Using the automatic
color pixel quantification tool in the Adobe Photoshop CS5 software, the BODIPY
493/503 staining-positive areas were estimated and calculated as a percentage of
the image total pixel size. Using a fluorimeter (Tecan, Männedorf, Switzerland),
AdipoRed assays were measured with excitation at 485 nm and emission at 572
nm. BODIPY 493/503 staining and AdipoRed assay were repeated in 4 independent
experiments.
ELISA. The protein levels of biglycan and fibronectin were analyzed by ELISA.
TSPCs (8 × 103 cells/cm2) were seeded in 6-well plates. After 3 days, the cell
supernatant and cell RIPA protein lysates were collected and frozen. Before ELISA,
the total protein of all samples was measured via DC protein assays (BioRad,
Munich, Germany). Secreted biglycan and fibronectin were determined using
mouse biglycan and fibronectin ELISA kits (Cloud-Clone Corp, Katy, TX, USA; and
Aviva Systems Biology, San Diego, CA, USA; respectively) according to the
manufacturer’s instructions. Two independent ELISA measurements were done with
two donors/genotypes. The data was expressed as target-specific concentration to
total protein content.
Semi-quantitative and qRT-PCR. Total RNA from tendon tissue and
adipogenic-stimulated TSPCs was isolated with Qiagen RNeasy Mini kit (Qiagen,
Hilden, Germany) and used for semi-quantitative and qRT-PCR. For cDNA
synthesis, 1 μg total RNA and AMV First-Strand cDNA Synthesis Kit (Invitrogen)
were used. Semi-quantitative PCR was performed with Taq DNA Polymerase
(Invitrogen) in MGResearch instrument (BioRad, Munich, Germany). For Primer
sequences and PCR conditions: Pparγ forward 5′ctccgtgatggaagaccactc3′, reverse
5′agactcggaactcaatggc3′; Lpl forward 5′gtctggctgacactggacaa3′, reverse 5′
tgggccattagattcctcac3′; Fabp4 forward 5′gaagcttgtctccagtcaaaa3′, reverse 5′
agtcacgcctttcataacacat3′; Gapdh forward 5′gagaggccctatcccaactc3′, reverse 5′
gtgggtgcagcgaactttat3′; PCR was performed with incubation at 94 °C for 5 min
followed by 30 cycles of a three step temperature program of 1 min at 94 °C, 20 s at
60 °C, and 30 s at 72 °C. The PCR reaction was terminated after a 7 min extension
at 70 °C. The band intensity of the amplified products in the gel was visualized,
photographed and analyzed using a gel imager (Vilber Lourmat, Eberhardzell,
Germany). The relative gene expression was quantified by densitometry and
normalized to the amount of Gapdh with ImageJ and presented as fold-change to
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WT. Quantitative RT-PCR of adipogenic and tenogenic associated gene markers
was performed using RealTime Ready Custom Panel 96–32+ plates (https://
configurator.realtimeready.roche.com) according to the manufacturer’s instructions
(Roche Applied Science, Mannheim, Germany). Briefly, PCR reactions were
pipetted on ice and each well contained 10 μl LightCycler 480 probes master mix,
0.2 μl cDNA and 9.8 μl PCR grade water. Plates were subsequently sealed and
centrifuged down for 15 s at 2100 rpm. The relative gene expression was calculated
as describe by Dex and co-workers.12 All PCR results have been reproduced
independently in five experiments.
Statistical analysis. Statistical differences between two groups were
determined using two-tailed unpaired Student’s t-test, or two-tailed non-parametric
Mann–Whitney test. Sample size and experimental reproduction are indicated for
each method. Results are presented as mean±S.D. Differences were considered
statistically significant according to values of *Po0.05, **Po0.01 and ***Po0.001.
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